selection should be individualized based on indication, efficacy, tolerability, and patient-specific factors
Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US food and drug administration adverse event reporting system
For once-weekly GLP-1 medications, follow your medications specific prescribing information.GLP-1s allows changing your injection day if at least 2 days (48 hours) have passed since your last dose
Combining tactics is key
(2) However, a disconcerting unintended consequence of these weight loss meds is that the potential health benefits of diet-induced weight loss are thought to be compromised by the weight-loss-associated loss of lean body mass, which could increase the risk of sarcopenia (low muscle mass and impaired muscle function)
Patients should ask about the recommended approach for their specific situation, which may include: Following a liquid-only diet for 24 hours before the procedure (in addition to the standard bowel preparation) Whether any medication adjustment is recommended based on individual risk factors What additional precautions the anesthesia team might take Diabetes management considerations are important for patients using GLP-1 agonists for glycemic control
